# Christopher B. Granger

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christopher-b-granger/

## Facts

| Field | Value |
| --- | --- |
| Citations | 131,401 |
| Field | Acute Myocardial Infarction Research |
| h-index | 158 |
| i10-index | 727 |
| Last Known Institution | Duke University |
| OpenAlex ID | https://openalex.org/A5014449865 |
| ORCID iD | https://orcid.org/0000-0002-0045-3291 |
| Works | 1,386 |

## Researcher papers

Showing 12 of 33.

- [2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-st-elevation-myocardial-infarction-2/)
- [Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial](https://scholariq.org/papers/effects-of-candesartan-in-patients-with-chronic-heart-failure-and-preserved-left/)
- [2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-st-elevation-myocardial-infarction-4/)
- [Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial](https://scholariq.org/papers/effects-of-candesartan-in-patients-with-chronic-heart-failure-and-reduced-left/)
- [2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-st-elevation-myocardial-infarction-3/)
- [Large-Scale Assessment of a Smartwatch to Identify Atrial Fibrillation](https://scholariq.org/papers/large-scale-assessment-of-a-smartwatch-to-identify-atrial-fibrillation/)
- [Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme](https://scholariq.org/papers/effects-of-candesartan-on-mortality-and-morbidity-in-patients-with-chronic-heart/)
- [2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death](https://scholariq.org/papers/2017-aha-acc-hrs-guideline-for-management-of-patients-with-ventricular-2/)
- [Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial](https://scholariq.org/papers/albiglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes-and/)
- [2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary](https://scholariq.org/papers/2013-accf-aha-guideline-for-the-management-of-st-elevation-myocardial-infarction/)
- [Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)](https://scholariq.org/papers/prediction-of-risk-of-death-and-myocardial-infarction-in-the-six-months-after/)
- [2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease](https://scholariq.org/papers/2016-acc-aha-guideline-focused-update-on-duration-of-dual-antiplatelet-therapy/)

## Researcher topics

- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)

## Researcher university

- [Duke University](https://scholariq.org/institutions/duke-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.